Yesterday, Oct. 27, 2015, 46 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $9.70 to $8,186,902.01.

Highlighted Stocks Traded by Insiders:

Owens-Corning (OC) - FREE Research Report

McMurray Michael C., who is Sr. VP and CFO at Owens-Corning, sold 11,000 shares at $45.52 on Oct. 27, 2015. Following this transaction, the Sr. VP and CFO owned 43,714 shares meaning that the stake was reduced by 20.1% with the 11,000-share transaction.

The shares most recently traded at $46.59, up $1.07, or 2.3% since the insider transaction. Historical insider transactions for Owens-Corning go as follows:

  • 4-Week # shares bought: 8,400
  • 4-Week # shares sold: 1,425
  • 12-Week # shares bought: 8,400
  • 12-Week # shares sold: 1,425
  • 24-Week # shares bought: 8,400
  • 24-Week # shares sold: 5,689

The average volume for Owens-Corning has been 1.6 million shares per day over the past 30 days. Owens-Corning has a market cap of $5.4 billion and is part of the industrial goods sector and materials & construction industry. Shares are up 28.15% year-to-date as of the close of trading on Tuesday.

Owens Corning, together with its subsidiaries, produces and sells glass fiber reinforcements and other materials for composite systems; and residential and commercial building materials worldwide. It operates in three segments: Composites, Insulation, and Roofing. The stock currently has a dividend yield of 1.47%. The company has a P/E ratio of 21.5. Currently, there are 7 analysts who rate Owens-Corning a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OC - FREE

TheStreet Quant Ratings rates Owens-Corning as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, increase in net income and attractive valuation levels. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Owens-Corning Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Haemonetics (HAE) - FREE Research Report

Hanlon Susan M, who is VP Finance at Haemonetics, sold 162 shares at $31.75 on Oct. 27, 2015. Following this transaction, the VP Finance owned 19,437 shares meaning that the stake was reduced by 0.83% with the 162-share transaction.

Burns Brian R, who is EVP, Global QA/RA at Haemonetics, sold 249 shares at $31.75 on Oct. 27, 2015. Following this transaction, the EVP, Global QA/RA owned 16,235 shares meaning that the stake was reduced by 1.51% with the 249-share transaction.

Davies Kent J, who is Chief Operating Officer at Haemonetics, sold 278 shares at $31.75 on Oct. 27, 2015. Following this transaction, the Chief Operating Officer owned 16,891 shares meaning that the stake was reduced by 1.62% with the 278-share transaction.

White Jonathan, who is Chief Science and Technology at Haemonetics, sold 250 shares at $31.75 on Oct. 27, 2015. Following this transaction, the Chief Science and Technology owned 29,848 shares meaning that the stake was reduced by 0.83% with the 250-share transaction.

Jesse Sandra, who is EVP and Chief Legal Officer at Haemonetics, sold 250 shares at $31.75 on Oct. 27, 2015. Following this transaction, the EVP and Chief Legal Officer owned 18,486 shares meaning that the stake was reduced by 1.33% with the 250-share transaction.

Selman Byron, who is President, Global Markets at Haemonetics, sold 191 shares at $31.75 on Oct. 27, 2015. Following this transaction, the President, Global Markets owned 11,296 shares meaning that the stake was reduced by 1.66% with the 191-share transaction.

The shares most recently traded at $33.31, up $1.56, or 4.68% since the insider transaction. Historical insider transactions for Haemonetics go as follows:

  • 4-Week # shares sold: 279
  • 12-Week # shares sold: 279
  • 24-Week # shares sold: 2,664

The average volume for Haemonetics has been 316,500 shares per day over the past 30 days. Haemonetics has a market cap of $1.6 billion and is part of the health care sector and health services industry. Shares are down 12.72% year-to-date as of the close of trading on Tuesday.

Haemonetics Corporation designs, manufactures, and markets blood management solutions. The company operates through North America Plasma, North America Blood Center and Hospital, Europe, Asia Pacific, and Japan segments. The company has a P/E ratio of 85.3. Currently, there are 3 analysts who rate Haemonetics a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HAE - FREE

TheStreet Quant Ratings rates Haemonetics as a hold. The company's strengths can be seen in multiple areas, such as its increase in net income, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, disappointing return on equity and weak operating cash flow. Get the full Haemonetics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Discover Financial Services (DFS) - FREE Research Report

Graf R. Mark, who is EVP & Chief Financial Officer at Discover Financial Services, sold 20,000 shares at $56.48 on Oct. 27, 2015. Following this transaction, the EVP & Chief Financial Officer owned 131,791 shares meaning that the stake was reduced by 13.18% with the 20,000-share transaction.

The shares most recently traded at $56.71, up $0.23, or 0.4% since the insider transaction. Historical insider transactions for Discover Financial Services go as follows:

  • 4-Week # shares sold: 91,000
  • 12-Week # shares sold: 162,000
  • 24-Week # shares sold: 433,182

The average volume for Discover Financial Services has been 3.7 million shares per day over the past 30 days. Discover Financial Services has a market cap of $24.7 billion and is part of the financial sector and financial services industry. Shares are down 14.17% year-to-date as of the close of trading on Tuesday.

Discover Financial Services operates as a direct banking and payment services company in the United States. It operates in two segments, Direct Banking and Payment Services. The stock currently has a dividend yield of 1.97%. The company has a P/E ratio of 11.7. Currently, there are 14 analysts who rate Discover Financial Services a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DFS - FREE

TheStreet Quant Ratings rates Discover Financial Services as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share and attractive valuation levels. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk, disappointing return on equity and a generally disappointing performance in the stock itself. Get the full Discover Financial Services Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.